Sequence-Controlled Spherical Nucleic Acids: Gene Silencing, Encapsulation, and Cellular Uptake.

Autor: Kaviani S; Department of Chemistry, McGill University, Montreal, Canada., Fakih HH; Department of Chemistry, McGill University, Montreal, Canada., Asohan J; Department of Chemistry, McGill University, Montreal, Canada., Katolik A; Department of Chemistry, McGill University, Montreal, Canada., Damha MJ; Department of Chemistry, McGill University, Montreal, Canada., Sleiman HF; Department of Chemistry, McGill University, Montreal, Canada.
Jazyk: angličtina
Zdroj: Nucleic acid therapeutics [Nucleic Acid Ther] 2023 Aug; Vol. 33 (4), pp. 265-276. Date of Electronic Publication: 2023 May 17.
DOI: 10.1089/nat.2022.0062
Abstrakt: Antisense oligonucleotides (ASOs) can predictably alter RNA processing and control protein expression; however, challenges in the delivery of these therapeutics to specific tissues, poor cellular uptake, and endosomal escape have impeded progress in translating these agents into the clinic. Spherical nucleic acids (SNAs) are nanoparticles with a DNA external shell and a hydrophobic core that arise from the self-assembly of ASO strands conjugated to hydrophobic polymers. SNAs have recently shown significant promise as vehicles for improving the efficacy of ASO cellular uptake and gene silencing. However, to date, no studies have investigated the effect of the hydrophobic polymer sequence on the biological properties of SNAs. In this study, we created a library of ASO conjugates by covalently attaching polymers with linear or branched [dodecanediol phosphate] units and systematically varying polymer sequence and composition. We show that these parameters can significantly impact encapsulation efficiency, gene silencing activity, SNA stability, and cellular uptake, thus outlining optimized polymer architectures for gene silencing.
Databáze: MEDLINE